Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation

被引:70
作者
Howie, D
Simarro, M
Sayos, J
Guirado, M
Sancho, J
Terhorst, C
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA
[2] Univ Pompeu Fabra Barcelona, Dept Ciencias Expt, Barcelona, Spain
[3] Univ Pompeu Fabra Barcelona, Salut Lab Immunol, Barcelona, Spain
[4] CSIC, Inst Parasitol & Biomed, Granada, Spain
关键词
D O I
10.1182/blood.V99.3.957
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD150 signaling lymphocytic activation molecule (SLAM), a T/B/dendritic cell surface glycoprotein, Is a costimulatory receptor involved in T-cell activation and is also a receptor for measles virus. CD150-induced signal transduction is controlled by SAP/SH2D1A, the gene that is aberrant In X-linked lymphoproliferative disease and familial hemophagocytic lymphohistiocytosis. This report shows that CD150 colocalizes with the T-cell receptor (TCR) following CD3 triggering in human peripheral blood T cells and is rapidly and reversibly tyrosine phosphorylated on TCR cross-linking. The Src-like kinases Lck and Fyn phosphorylate tyrosine residues in the cytoplasmic tail of CD150. The results demonstrate that the SAP protein has 2 modes of binding to CD150. Binding to the motif Thr-IIe-Tyr281Ala-GIn-Val occurs in a phosphotyrosine-independent fashion and to the motif Thr-Val-Tyr327Ala-Ser-Val in a phosphotyrosine-dependent manner. Within both SAP binding motifs the threonine residue at position -2 to tyrosine is essential to stabilize the interaction irrespective of tyrosine phosphorylation, a feature unique to the SAP SH2 domain. A leucine residue, Leu278, further stabilizes non-phospho binding of SAP to Tyr281 of CD150. SAP blocking of the tyrosine phosphatase SHP-2 occurs primarily on Tyr281 of CD150 because SHP-2 requires both Tyr281 and Tyr327 for binding to CD150, and SAP binds to nonphosphorylated Tyr281. CD150 exhibits lateral mobility, segregating into intercellular contacts. The lateral mobility and homophilic clustering of CD150 between neighboring cells is not dependent on SAP/CD150 interaction. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:957 / 965
页数:9
相关论文
共 29 条
[1]   Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene [J].
Arico, M ;
Imashuku, S ;
Clementi, R ;
Hibi, S ;
Teramura, T ;
Danesino, C ;
Haber, DA ;
Nichols, KE .
BLOOD, 2001, 97 (04) :1131-1133
[2]  
Aversa G, 1997, J IMMUNOL, V158, P4036
[3]  
Carballido JM, 1997, J IMMUNOL, V159, P4316
[4]  
Castro AG, 1999, J IMMUNOL, V163, P5860
[5]   Integration of T cell receptor-dependent signaling pathways by adapter proteins [J].
Clements, JL ;
Boerth, NJ ;
Lee, JR ;
Koretzky, GA .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :89-108
[6]   A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION [J].
COCKS, BG ;
CHANG, CCJ ;
CARBALLIDO, JM ;
YSSEL, H ;
DEVRIES, JE ;
AVERSA, G .
NATURE, 1995, 376 (6537) :260-263
[7]   Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].
Coffey, AJ ;
Brooksbank, RA ;
Brandau, O ;
Oohashi, T ;
Howell, GR ;
Bye, JM ;
Cahn, AP ;
Durham, J ;
Heath, P ;
Wray, P ;
Pavitt, R ;
Wilkinson, J ;
Leversha, M ;
Huckle, E ;
Shaw-Smith, CJ ;
Dunham, A ;
Rhodes, S ;
Schuster, V ;
Porta, G ;
Yin, L ;
Serafini, P ;
Sylla, B ;
Zollo, M ;
Franco, B ;
Bolino, A ;
Seri, M ;
Lanyi, A ;
Davis, JR ;
Webster, D ;
Harris, A ;
Lenoir, G ;
St Basile, GD ;
Jones, A ;
Behloradsky, BH ;
Achatz, H ;
Murken, J ;
Fassler, R ;
Sumegi, J ;
Romeo, G ;
Vaudin, M ;
Ross, MT ;
Meindl, A ;
Bentley, DR .
NATURE GENETICS, 1998, 20 (02) :129-135
[8]   The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus [J].
Howie, D ;
Sayos, J ;
Terhorst, C ;
Morra, M .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :474-478
[9]  
HSU EC, 2001, VIROLOGY, P279
[10]   Expression of soluble human signaling lymphocytic activation molecule in vivo [J].
Isomäki, P ;
Aversa, G ;
Chang, CCJ ;
Luukkainen, R ;
Nikkari, S ;
Toivanen, P ;
deVries, JE ;
Punnonen, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) :114-118